Patents by Inventor David G. Atkins

David G. Atkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Catalytic molecules
    Patent number: 7355035
    Abstract: The present invention relates to DNAzymes which are targeted against mRNA molecules encoding EGR-1 (also known as Egr-1 and NGFI-A). The present invention also relates to compositions including these DNAzymes and to methods of treatment involving administration of the DNAzymes.
    Type: Grant
    Filed: January 11, 2000
    Date of Patent: April 8, 2008
    Assignee: Unisearch Limited
    Inventors: David G. Atkins, Andrew R. Baker, Levon Michael Khachigian
  • Codeinone reductase from alkaloid poppy
    Patent number: 7193127
    Abstract: The present invention concerns codeinone reductase from alkaloid poppy plants, the polynucleotides encoding the enzyme, transgenic plants transformed or transfected with polynucleotide(s) encoding codeinone reductase and to the production of alkaloids from transformed or transfected poppy plants.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: March 20, 2007
    Assignee: Johnson & Johnson Research Pty. Limited
    Inventors: Toni M. Kutchan, Meinhard H. Zenk, David G. Atkins, Anthony J. Fist
  • Cytochrome P450 reductases from poppy plants
    Patent number: 7037674
    Abstract: The present invention relates to production of alkaloids from poppy plants and in particular togenes encoding enzymes in the alkaloid pathway, to proteins encoded by the gens, to plants transformed or transfected with the genes and to methods of altering alkaloid content or blend of poppy plants.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: May 2, 2006
    Assignee: Johnson & Johnson Research PTY Limited
    Inventors: Toni M. Kutchan, Meinhart H. Zenk, David G. Atkins, Anthony J. Fist
  • Treatment of inflammatory and malignant diseases
    Publication number: 20030148971
    Abstract: The present invention relates to DNAzymes which are targeted against mRNA molecules encoding RelA(p65) (a subunit of NF-&kgr;B). The present invention also relates to compositions including these DNAzymes and to methods of treatment involving administration of the DNAzymes.
    Type: Application
    Filed: February 4, 2002
    Publication date: August 7, 2003
    Inventors: Malcolm Lovell Handel, Ly Quoc Quynh Nguyen, David G. Atkins, Murray John Cairns
  • Ribozyme nucleic acids and methods of use thereof for controlling viral pathogens
    Patent number: 6451603
    Abstract: The invention consists of a non-naturally occurring nucleic acid molecule capable of blocking or interfering with a replicative intermediate of a virus, a virusoid, or a viroid. The nucleic acid molecule may contain a ribozyme or a plurality of ribozymes. Alternatively, the nucleic acid molecule may be an antisense nucleic acid molecule. The ribozyme may be a hairpin ribozyme, a hammerhead ribozyme, an RNAase P ribozyme, a minizyme, or other catalytic RNA molecule. The virus may be an animal, a mammalian, a plant, a fungal, a protozoan, a yeast, a bacterial virus, or a human virus. The nucleic acid molecule may be expressed in the cell or it may be preformed and administered ex vivo. The present invention contemplates methods of controlling infection of a pathogenic infectious agent in a plant or animal.
    Type: Grant
    Filed: March 2, 1995
    Date of Patent: September 17, 2002
    Assignee: Gene Shears Pty. Limited
    Inventors: David G. Atkins, Wayne L. Gerlach, Mark J. Young